PurposeTo explore the efficacy and safety of L-asparaginase in newly-diagnosed extranodal nature killer (NK)/T —cell lymphoma (ENKTL), we conducted a prospective phase II study of L-asparaginase, cyclophosphamide, vincristine, doxorubicin and dexamethasone (CHOP-L) regimen in combination…
Source: A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type
Monday, July 1, 2013
A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment